医药制造
Search documents
常州滨开区交卷!跨越不止“亿”点点!
Xin Lang Cai Jing· 2026-01-18 21:30
(来源:新华日报) 工业总产值、总销售双双破千亿,斩获全国绿色工业园区、全国智慧化工园区、中国化工园区30强 (2024年第11位)、"十四五"具有竞争力优势化工园区(第12位)、中国(江苏)自由贸易试验区联动 创新发展区…… 锚定"改革创新引领区、统筹发展示范区、争先进位先行区"发展定位不动摇,以"大抓项目再突破,改 革创新开新局"为抓手,常州滨江经济开发区(以下简称"滨开区")交出了一份厚重务实、亮点纷呈 的"十四五"高质量发展答卷,成为沿江高质量发展的标杆典范。 实力跃升,用"沿江空间"造"高地价值" 用占全市1/25的土地、1/30的人口,扛起了全市6.1%规上工业总产值和7.3%进出口总额的发展重任,核 心指标实现跨越式增长,用"小空间"创造了"大价值"。 经济规模再攀高:2025年预计GDP突破480亿元,较"十三五"增长41%;规上工业总产值达1120亿元, 较2020年增长58.3%;一般公共预算收入34.8亿元,是2020年的1.88倍,为发展筑牢经济根基。 市场活力有增益:累计新增经营主体近9300家,其中新设企业2750家;规上工业企业从287家增至385 家,创业就业氛围愈发浓厚。 企 ...
2025年国民经济运行数据将公布,这些投资机会最靠谱|下周关注
Di Yi Cai Jing Zi Xun· 2026-01-18 08:35
Group 1 - The National Bureau of Statistics will announce the 2025 national economic operation data on January 19, 2026 [1] - The People's Bank of China will lower the re-lending and re-discount rates by 0.25 percentage points effective January 19, 2026 [2] - The Shanghai and Shenzhen Stock Exchanges will implement a new financing margin requirement, increasing the minimum margin ratio from 80% to 100% starting January 19, 2026 [3] Group 2 - The World Economic Forum will hold its 56th annual meeting in Davos, Switzerland from January 19 to 23, 2026, with nearly 3,000 leaders from over 130 countries attending [4] - The January Loan Prime Rate (LPR) will be announced on January 20, 2026, with the previous rates remaining unchanged for seven consecutive months [5] - Domestic refined oil prices are expected to increase by 75 yuan per ton based on the average crude oil price as of January 16, 2026 [6] Group 3 - Wohuah Pharmaceutical will be the first company to release its 2025 annual report on January 20, 2026, projecting a net profit of 80 million to 115 million yuan, representing a year-on-year growth of 119.76% to 215.90% [7] - A total of 39 companies will have their restricted shares unlocked next week, with a total of 3.447 billion shares worth approximately 464.99 billion yuan [8] - The top three companies by market value of unlocked shares are: Xingtum Measurement Control (13.13 billion yuan), Shanxi Coking Coal (6.968 billion yuan), and Xingfu Electronics (5.007 billion yuan) [8] Group 4 - Three new stocks will be issued next week: Zhenstone Co., Ltd. and Agricultural University Technology will open for subscription on January 19, 2026, while Shimon Co., Ltd. will open for subscription on January 23, 2026 [11] - The issue price for Zhenstone Co., Ltd. is 11.18 yuan per share, and for Agricultural University Technology, it is 25.00 yuan per share [12]
北交所策略专题报告:开源证券融资杠杆适度收敛,聚焦北交所的“水位”提升空间
KAIYUAN SECURITIES· 2026-01-18 08:12
北交所策略专题报告 2026 年 01 月 18 日 融资杠杆适度收敛,聚焦北交所的"水位"提升空间 ——北交所策略专题报告 北交所研究团队 诸海滨(分析师) zhuhaibin@kysec.cn 证书编号:S0790522080007 融资余额可为投资者情绪变化的投资线索,北证融资余额仅约为创业板 1/3 2026 年 1 月 14 日,经中国证监会批准,沪深北交易所发布通知调整融资保证金 比例,将投资者融资买入证券时的融资保证金最低比例从 80%提高至 100%。2023 年 8 月,沪深北交易所将融资保证金比例从 100%降低至 80%,融资规模和交易 额稳步上升。近期,融资交易明显活跃,市场流动性相对充裕,根据法定的逆周 期调节安排,适度提高融资保证金比例回归 100%,有助于适当降低杠杆水平。 整体来看,北交所融资融券业务类型以融资为主,融资融券业务不仅为市场提供 了额外的流动性,还能反映出市场情绪和投资者对市场未来走势的预期。从北交 所融资余额趋势变化来看,1)2023 年 11 月、2024 年 9 月底、2025 年 2 月和 2025 年 12 月四轮北交所行情拉动了北交所融资融券交易的活跃 ...
下周关注丨2025年国民经济运行数据将公布,这些投资机会最靠谱
Di Yi Cai Jing Zi Xun· 2026-01-18 01:13
Economic Data and Policy Changes - The National Bureau of Statistics will announce the 2025 national economic operation data on January 19 [1] - The People's Bank of China will lower the re-lending and re-discount rates by 0.25 percentage points starting January 19, 2026, with new rates set at 0.95%, 1.15%, and 1.25% for different terms [2] - The Shanghai and Shenzhen Stock Exchanges will implement a new financing margin requirement, increasing the minimum margin from 80% to 100% effective January 19 [3] Global Events - The World Economic Forum will hold its 56th annual meeting in Davos, Switzerland, from January 19 to 23, gathering nearly 3,000 leaders from over 130 countries [4] Market Updates - The Loan Prime Rate (LPR) for January will be announced on January 20, with the previous rates remaining unchanged for seven consecutive months at 3.0% for one year and 3.5% for five years [5] - Domestic refined oil prices are expected to increase by 75 yuan per ton based on the average crude oil price of $61.09 per barrel [6] Company Earnings Reports - Wohuah Pharmaceutical will be the first to release its 2025 annual report on January 20, projecting a net profit of 80 million to 115 million yuan, representing a year-on-year growth of 119.76% to 215.90% [7] Stock Unlocking Events - A total of 39 companies will have their restricted shares unlocked next week, with a total of 3.447 billion shares and a market value of approximately 464.99 billion yuan [8] - The companies with the highest unlocking values include Xingtum Measurement and Control (131.3 billion yuan), Shanxi Coking Coal (69.68 billion yuan), and Xingfu Electronics (50.07 billion yuan) [8] New Stock Opportunities - Three new stocks will be issued next week: Zhenstone Co., Ltd. and Agricultural University Technology will open for subscription on January 19, while Shimon Co., Ltd. will open on January 23 [11] - The issuance prices are set at 11.18 yuan per share for Zhenstone and 25.00 yuan per share for Agricultural University Technology [12]
百股年报预告来袭,多行业亮点频现
Huan Qiu Wang· 2026-01-17 00:57
Group 1 - In January, nearly 230 stocks have disclosed their 2025 annual report forecasts, with over 280 listed companies releasing performance forecasts, and nearly half of the 2025 net profit attributable to shareholders expected to be positive [1] - Among the approximately 140 stocks with positive performance forecasts, the sectors of basic chemicals, electronics, automotive, pharmaceutical and biotechnology, and machinery and equipment account for a combined share of nearly 56.6% [3] - There are 48 stocks expected to see a doubling in growth rate, with Huisheng Biological being the only stock projected to exceed a 10-fold increase in performance [3] Group 2 - A report from Everbright Securities indicates that the company is benefiting from an upturn in the storage cycle, with performance improvements expected despite a decline in storage prices starting from Q3 2024 [4] - The demand for high-performance inference services driven by the AI wave is expected to shift storage demand towards QLC Enterprise SSDs, leading to price increases for NAND Flash products [4] - From Q2 2025, as storage prices stabilize and key projects are gradually delivered, the company's sales revenue and gross margin are expected to improve [4]
让创新不再“卡在路上”,山东医药改革在补哪块短板?
Feng Huang Wang Cai Jing· 2026-01-17 00:11
医药创新领域长期存在一个难解的困境——"实验室里不缺成果,市场却等不到好药。" 症结并不在于创新本身,而在于创新成果从研发到应用的转化链条不够顺畅。在研发初期,创新药品和 医疗器械往往面临研发路径不清、注册策略不明等问题;进入临床阶段,又受到试验资源紧张、伦理审 查重复等因素制约;即便完成研发,在挂网、支付等环节也难以迅速放量,创新成果由此被层层"卡 住"。这既是产业发展中的现实难题,也直接关系群众健康福祉。 日前,山东省政府办公厅印发《关于全面深化药品医疗器械监管改革促进医药产业高质量发展的实施意 见》(下称《实施意见》),围绕医药产业发展的难点堵点,推出29条改革举措,着力打通创新成果转化 链条。这释放出一个清晰信号:药械创新,正在从"企业单打独斗"走向"制度协同发力"。 01 从"各管一段"到"一条链",改革首先破的是"碎片化" 过去,医药创新被分割在不同环节:科技、药监、卫生健康、医保"各管一段",政策看似不少,却难以 形成合力,创新主体由此在多重规则之间反复碰壁。 在山东这轮改革中,一个格外值得关注的变化是——监管部门的角色,正在向"创新伙伴"转变。 以药监部门为例,对具有明确临床价值的创新药械,不 ...
我国自主研发注射用硼药进入临床试验阶段
Ren Min Wang· 2026-01-16 22:34
Core Viewpoint - The article highlights the approval of the boron-10 injection by China's National Medical Products Administration, marking the entry into Phase I clinical trials for a novel cancer treatment method known as Boron Neutron Capture Therapy (BNCT) [1] Group 1: Drug Development - The boron-10 injection has received the Clinical Trial Approval Notification, allowing it to proceed to Phase I clinical trials [1] - The clinical cooperation project for BNCT is a joint effort involving China National Nuclear Corporation, Lanzhou University, Fujian Ruisi Technology, and Fujian Medical University Union Hospital [1] Group 2: Treatment Efficacy - BNCT is a targeted radiation therapy that shows promising results for recurrent, infiltrative, and locally metastatic tumors, particularly for recurrent gliomas, head and neck tumors, malignant melanomas, and malignant meningiomas [1] - Initial clinical trials have also shown effectiveness for other common cancers such as liver cancer, lung cancer, and prostate cancer [1] Group 3: Mechanism and Potential - The therapy's mechanism relies on the specific affinity of boron-10 compounds for cancer cells, which allows for targeted destruction of tumor cells while protecting surrounding healthy tissue [1] - The approval of the boron-10 injection is expected to accelerate the industrialization of BNCT, positioning it as a breakthrough direction in cancer treatment [1]
家门口选好岗!连云港赣榆2026年新年招聘会暖心启幕
Xin Lang Cai Jing· 2026-01-16 12:57
转自:扬子晚报 为扎实做好稳就业、保就业工作,日前,连云港市赣榆区2026年"帮扶暖民心 就业解民忧"新年专场招 聘会在吾悦广场火热开启。本次活动由赣榆区人力资源和社会保障局联合多家单位主办,不仅汇聚海量 优质岗位,更创新服务模式,为求职者和企业搭建起高效对接的桥梁,让新年就业"开门红"的暖意浸润 民心。 此次新年专场招聘会,是赣榆区落实稳就业、保民生政策的生动实践。春节前后正是大量务工人员、高 校毕业生集中返乡的黄金期,赣榆区人社局将以此为契机,持续组织开展多场次、多形式的线上线下招 聘活动,聚焦高校毕业生、返乡务工人员、就业困难人员等重点群体的就业需求,推出更多专业化就业 服务举措,将岗位信息送到就业市场的最前端,让就业服务更有温度、更接地气,切实保障实体经济高 质量发展的人才需求。 通讯员 李道山 滕怀超 扬子晚报/紫牛新闻记者 张凌飞 本次招聘会还特别设立无锡惠山专区,34家外地企业带来927个高薪岗位,既为赣榆求职者拓宽了就业 选择空间,也实现了本地招聘与跨区域劳务协作的有效联动,助力南北结对帮扶工作走深走实。 为打破时空限制,本次招聘会采用"线下直聘+线上云聘"双线并行模式。邀请企业代表详细介绍岗 ...
东莞证券财富通每周策略-20260116
Dongguan Securities· 2026-01-16 10:28
Market Overview - The market experienced a pullback after a strong rally, with mixed performance across the three major indices. The Shanghai Composite Index fell by 0.45%, while the Shenzhen Component rose by 1.14%, and the ChiNext Index increased by 1.00% [1][2][8] - In the first half of the week, trading volume exceeded 3 trillion yuan, and margin trading balances rose significantly, with the Shanghai index reaching a ten-year high. However, market sentiment cooled in the latter half due to regulatory adjustments [1][2][8] Economic Indicators - Exports showed resilience at the end of 2025, with December exports in USD terms growing by 6.6% year-on-year, surpassing 350 billion USD, marking a historical high. Integrated circuits and automobiles contributed over 60% of this growth [9][10] - The Consumer Price Index (CPI) rose by 0.8% year-on-year in December 2025, the highest since March 2023, indicating an improving price environment. The Producer Price Index (PPI) saw a narrowing decline of 1.9% year-on-year [9][10] Federal Reserve Outlook - The U.S. labor market data was mixed, with non-farm payrolls adding 50,000 jobs in December, below expectations. However, the unemployment rate fell to 4.4%, leading to increased expectations that the Federal Reserve will pause interest rate cuts in January [10][11] - Inflation remained stable, with the December CPI at 2.7% year-on-year, supporting the Fed's accommodative policy stance. Market participants expect cumulative rate cuts of about 50 basis points in 2026 [10][11] Regulatory Adjustments - The adjustment of margin trading requirements by the Shanghai and Shenzhen stock exchanges aims to cool overheated market sentiment rather than suppress it. The minimum margin requirement for new financing contracts has been raised from 80% to 100% [11][12] - The People's Bank of China has implemented structural interest rate cuts to support economic transformation, with a 0.25 percentage point reduction in various monetary policy tools [12][13] Sector Recommendations - Investment focus is recommended on sectors such as non-ferrous metals, TMT (Technology, Media, and Telecommunications), machinery, power equipment, and basic chemicals [14]
山东省药监局:“监管+服务”双轮驱动医药产业高质量发展
Qi Lu Wan Bao· 2026-01-16 10:18
齐鲁晚报.齐鲁壹点记者秦聪聪 一是守牢安全底线。我们坚持守底线保安全,以新安全格局保障新发展格局。不断完善地方属地、部门管理、企业主体"三位一体"责任落实体系,在全国 率先以党内文件出台药品安全党政同责规定,压实地方属地和部门管理责任。指导企业坚持"质量为本,以质取胜",新华制药(000756)通过德国默克6 年的质量管理考核,签订年产值40亿元的跨国合作项目,成为全球医药合作"双向奔赴"的典范,也为全国药品企业主体责任落实树立了标杆。推动安全风 险防范关口前移,每季度开展全系统和各领域药品安全风险会商,加强常态化风险隐患排查治理。强化分级分类监管,扎实开展药品经营"清源"行动,针 对临床试验、委托生产、集采中选、网络销售等重点环节,强化靶向发力。药品抽检合格率达99.8%以上,高于全国平均水平。深化"罚帮并重",在严格 处罚的同时,安排专人对违法企业进行帮扶,防范化解潜在风险,提升产品质量水平。 二是强化改革赋能。以改革促创新,积极对上争取支持,将山东纳入国家药监局药品和医疗器械审评检查京津冀分中心服务范围,成为唯一辐射京津冀之 外的省份,为强化京津冀鲁标准互认、监管协同打下坚实基础。获批全国首批优化药品补 ...